📣#Gastroparesis and functional dyspepsia should be considered part of the same spectrum of gastric neuromuscular disorders
Treatment (historical)
💊Metoclopramide (only FDA-approved therapy)
🧠 tardive dyskinesia risk: 0.1% per 1000 patient years
💉BoTox to pylorus: no better than placebo, but ongoing research
🔌Gastric electrical stimulation (questionable efficacy, may help nausea/vomiting)
💊Metoclopramide (only FDA-approved therapy)
🧠 tardive dyskinesia risk: 0.1% per 1000 patient years
💉BoTox to pylorus: no better than placebo, but ongoing research
🔌Gastric electrical stimulation (questionable efficacy, may help nausea/vomiting)
Newer treatments
💊5-Hydroxytryptamine 4 (5-HT4) agonists: prucalopride, felcisetrag
💊Neurokinin-1 receptor (N1KR) antagonists: aprepitant, tradipitant
🧠Vagal nerve stimulation
🔪gastric peroral endoscopic myotomy (G-POEM)
💊5-Hydroxytryptamine 4 (5-HT4) agonists: prucalopride, felcisetrag
💊Neurokinin-1 receptor (N1KR) antagonists: aprepitant, tradipitant
🧠Vagal nerve stimulation
🔪gastric peroral endoscopic myotomy (G-POEM)
A note on #diet
Some benefit from ⬇️ fats; consuming smaller, more frequent meals, and avoiding excess fiber
⚠️Watch out for ARFID
55% of #gastroparesis patients may have eating disorder
🟢ARFID most common
🔵anorexia nervosa also prevalent
Some benefit from ⬇️ fats; consuming smaller, more frequent meals, and avoiding excess fiber
⚠️Watch out for ARFID
55% of #gastroparesis patients may have eating disorder
🟢ARFID most common
🔵anorexia nervosa also prevalent
Loading suggestions...